Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 814.50, up by 5.55 points or 0.69% from its previous closing of Rs. 808.95 on the BSE.

The scrip opened at Rs. 809.00 and has touched a high and low of Rs. 814.50 and Rs. 797.00 respectively. So far 127708 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1010.10 on 25-May-2015 and a 52 week low of Rs. 706.40 on 24-Nov-2015.

Last one week high and low of the scrip stood at Rs. 838.05 and Rs. 802.50 respectively. The current market cap of the company is Rs. 195426.35 crore.

The promoters holding in the company stood at 54.97% while Institutions and Non-Institutions held 35.37% and 9.65% respectively.

Sun Pharmaceutical Industries and its subsidiaries or associate companies (Sun Pharma) along with Indian Council of Medical Research (ICMR), Ministry of Health & Family Welfare (MOHFW), Government of India, Government of Madhya Pradesh, have announced India’s first public-private-partnership agreement for Malaria Free India and other innovation in preventive health.

Under the aegis of this unique public-private-partnership, ICMR, MOHFW, Government of India, Government of Madhya Pradesh and Sun Pharma will establish a malaria elimination demonstration project titled Malaria Free India, to support the national framework for elimination of malaria in India.

The demonstration project will be launched in one of the most malaria endemic districts of Madhya Pradesh and implemented in a phased manner, beginning with Mandla district of Madhya Pradesh. The public-private-partnership stakeholders will execute the malaria elimination programme over a span of 3 to 5 years covering over 1,200 villages in Mandla district.